← Back to all trials
Completed
NCT03847948
Biological Factors Associated With Subclinical Valvular Thrombosis
Conditions: Aortic Stenosis
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Enrollment: 166
Sponsor: Hospital San Carlos, Madrid
Location: Hospital Clinic Barcelona
Summary
A prospective, multicentric cohort study including 166 patients with symptomatic aortic stenosis treated with transcatheter aortic valve implantation (TAVI).
\- The main objective is to determine whether the high residual platelet reactivity rates in patients undergoing TAVI is associated with the occurrence of clinical and / or subclinical prosthetic valve thrombosis measured by echocardiography and multi-slice computerized tomography
Eligibility Criteria
Inclusion Criteria:
* Patients with severe symptomatic aortic stenosis who it was accepted to be treated with TAVI by a multidisciplinary team "Heat Team".
* TAVI was successfully implanted (according to Valve Academic Research Consortium II criteria) and are under treatment with double antiplatelet therapy.
* Signed informed consent to participate in this study.
Exclusion Criteria:
* Age under 18 years and pregnant or of childbearing age.
* Acute Recent stroke recent \
Source: ClinicalTrials.gov (NCT03847948). StuddyBuddy aggregates publicly available trial information.